Emergency Medical Research Journals

Emergency Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Schreckinger M et al. – Therapeutic moderate hypothermia is as effective, or more effective, than most other treatments for ICH. If used for 2–3 days or less there is no evidence that it causes clinically significant adverse events. The lack of consistent evidence that hypothermia improves long–term neurologic outcome should not preclude consideration of its use for the primary treatment of ICH since no other ICP therapy is held to this standard.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address